Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer ProgramsPublished: October 10th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Pfizer Files Lawsuits Against Metsera and Novo Nordisk
2
Roundup: Biotech’s Most Recent Strategic Partnerships and Exclusive Licensing Agreements
3
Join Us Tonight: Inside Trump’s Drug Price Plan
4
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
5
